By Dr. Jamie Turndorf
JT – What personal event launched your career of over a half-century journey in treating cancer?
SJ – This is a long story because my interest in treating cancer began back in 1967 or 1968 when I was in Montreal, Canada, and found Dr. Max Gerson’s book, A Cancer Therapy – Results of Fifty Cases. I was at the beginning of my practice and knew nothing about cancer, but this book fascinated me since also I could see some correlation with the work of Dr. Bernard Jensen concerning the use of fresh organic vegetable juice, especially carrot and beet juice. Max Gerson’s approach made sense to me since it offered cancer theory and a diet.
In truth, I have in my memory the sad story of both my father and mother who both died of cancer. At that time our house smelled of all kinds of medications that caused me to develop repulsion for these remedies. This maybe is the reason why I decided to spend more time learning about cancer—having been my fight for over the past 50 years. However, I found myself limited and decided to learn more about cancer and also iridology, since I started to use it in my practice from Dr. Jensen’s teaching.
So, I decided to close my consulting office and flew back to Europe, then traveled to Germany to see if I could get more information about cancer and therapy. I was lucky to meet pioneers like Dr. Paul G. Seeger, cancer researcher, biologist, and physician, who conducted several experiments, beginning in 1938 at the Robert Koch Institute in Berlin. In 1957, he demonstrated that the cause of cancer and its growth was the destruction of important enzymes in the respiratory chain in the mitochondria—a discovery was made similar to Otto Warburg’s. He published over 300 scientific papers and several books and was twice nominated for the Nobel Prize in 1979 and again in 1980. Unfortunately, today, Dr. Seeger remains unknown even after having been a great researcher.
I also met Dr. Siegfried Wolz, a biotechnology engineer who also collaborated with Dr. P. G. Seeger. S. Wolz was the owner of the Wolz Laboratory; we kept in contact over many years before he died. Dr. Seeger asked him to develop a product that could regenerate cellular respiration. He then developed the famous Enzyme Yeast Cells during the same year we had met. In 1990, they both published a very important book called, Successful Biological Control of Cancer, offering a full description of his research since 1938, about the theories on mitochondria and cellular respiration, explaining how to reactivate cellular respiration using selected enzymes and other compounds. Now for me, it was a basis to understand what cancer is and to start treating it.
My first article published in the Townsend Letter in 1999, was about the theory of cellular respiration. To my surprise, I received so many letters from both naturopaths as well as physicians showing major interest. In 2011, I subsequently published a more complete article.
JT – You were born in France and immigrated to the US in 1959 where you met Dr. Bernard Jensen. Then you spent time in Canada where you began your studies in naturopathy after which you came back to France, traveled to Germany, and finally settled in Portugal. Why did you choose to permanently reside in Portugal?
SJ – We can never know what life has decided for you, what you will do, or where you will go. For me, it is like a puzzle. When very young, I decided to immigrate by myself to the US. Luckily, I landed in Los Angeles where under some predestined circumstance, I met Dr. Bernard Jensen, who profoundly changed my life and guided me to this new world of natural medicine. The reason why I then moved to Montreal was to enroll in a course of naturopathy in the French language rather than in English since I also didn’t know where to go to study in the US; but at the same time, I started to read many health books. I also began my first homeopathy correspondence course with the French College of Homeopathy in Paris. Before graduation, I opened a consulting office and was lucky to have many patients. But as previously explained I found my knowledge limited and decided to return to France and traveled to Germany. So you see for some reason, life brought me back to Europe.
In Paris, I registered for advanced courses at the French School of Naturopathy in evening classes and then collaborated to offer some courses in iridology and Dr. Jensen’s nutritional and detox method. The French Federation of Naturopathy organized a yearly congress where I met a young Portuguese doctor, speaking fluent French who was attracted by my knowledge of naturopathy.
Back then, iridology was practically unknown in Portugal. He invited me to come and work in his Lisbon clinic. Of course, the language could at first be an obstacle, but I was not very satisfied with my life in France after living in the US and Canada. I decided to accept his offer and see what life would bring me.
One year later I met my wife Lucie, a professor of French philosophy, who was very enthusiastic about the philosophy of naturopathic medicine and natural food. We decided to open my own consulting office, while at the same time we created a small company to import the best natural products for our patients, including the important Enzyme Yeast Cell preparation from Dr. Wolz. Of course, my wife gave up her profession, and we began to educate people, publish our health magazine, started to travel, and then later opened several health food stores. In 1976 I opened my first large clinic in Lisbon, where the weather was excellent, the food still natural, etc. Now I permanently reside in Portugal because I was well accepted by patients, people who were very open, friendly, who understood how I treated disease. They were especially attracted by iridology. My mission was to help them and offer some meaningful education. Of course, we grew and developed a large [line of] natural products.
In 1985, we decided to open our own pharmaceutical manufacturing facility, not only for pharmaceutical products but for high-quality natural products to fulfill the need of my patients and supply our health food stores. Today we export to about 28 countries.
In 1983, I opened a second, large, three-story clinic outside of Lisbon that became a school where doctors from several countries came for my teaching. This explains the reason why I settled in Portugal; but of course, I never forget the US, having made many good contacts with doctors. I went back several times to lecture, offer seminars, and collaborated with some institutions. I even obtained a license as a naturopathic physician and even as a homeopathic physician, but this was many years ago. I also traveled to lecture in about 36 countries worldwide.
JT– In your book you speak about your personal experience in treating cancer. Please tell us how you approach this disease.
SJ – When I speak about my personal experience, I am referring to having a cancer patient facing you, which is one aspect of the disease along with the disease itself. Just treating the cancer is not like treating Parkinson’s disease or arthritis since cancer is a killing disease that causes serious physical and psychological suffering. We have to know how to handle and help patients in this battle. I felt it takes years or even decades before you understand what cancer means and how to approach both the disease and the patient.
I have treated thousands of cancer patients of all types, grades, and ages; but this disease is so complex that you never finish discovering more mechanisms. You never know when cancer cells start to develop resistance, what mechanisms support the migration of cancer cells; and of course, it all depends on the patient’s attitude, lifestyle, dietary style, the way he/she reacts when diagnosed. We also must consider whether or not if the cancer was previously diagnosed without metastasis or as cancer with metastasis, which makes an overwhelming difference when treating the disease.
Science is far from discovering everything there is to know about the human body, especially what is cancer? On one hand, you have to describe the disease to your patient, collect several factors associated with lifestyle, all the organic function or dysfunction including the nervous system, the energy level being also important, along with an emotional profile, oxidative stress profile, and the nutritional profile maybe through an LBA (Live Blood Analysis) examination. But if you want to treat patients like I do, you do molecular markers testing, and only then do you have a better way to understand the cancer of each patient. Maybe the patient needs a chemical brain analysis as I offer, to get an idea about the function of the neurotransmitters, which also may affect the immune system and need to be balanced.
One other very important step when treating cancer is to determine the activity of the p53 tumor suppressor gene and p53 protein levels. For instance, a high level of mutated p53 is considered a poor prognosis and you have to know how to reverse this situation. This is the way I approach the disease, but it requires time to learn and be organized. I believe the p53 gene is the most important gene protecting us against cancer. Just as an example, a few years ago a team of researchers from the US and Israel made an investigation with elephants to find out why they practically do not die from cancer.
In their lifetime elephants develop only a 5% risk of cancer and a 5% risk of dying from cancer, while for a human it goes up to 55%. So where is the answer? Could you believe this, but the answer is associated with the p53 gene, but why? While humans have only two copies of the p53 gene, elephants have 40 copies and are highly protected. The published article suggests that the p53 gene may be the answer to cancer prevention and treatment.
JT – Can you give us an overview of your research on this topic?
SJ – Let’s say that for the past 15 years I have concentrated my research in two main directions. First, I focus on apoptosis—related to the function of the p53 tumor suppressor gene since p53 mutation is necessary for the development of many forms of cancer along with other apoptotic players and inhibitors of apoptosis. We then perform specialized blood testing on the patient where the results give you the information you need for diagnosis, prognosis, treatment follow-up, and how to build your treatment.
Now, remember that cancer cells can be killed directly or indirectly even with chemotherapy, but always through apoptosis. Dysregulation of apoptosis occurs in cancer cells and has not only been implicated in tumor progression but also plays an important role in response to therapy; this is important to remember. Now doing such testing gives you the result you need to tailor your treatment, and it works also as a prognosis but sometimes you get a very bad prognosis. We may call this diagnostic procedure molecular markers testing, and we do it in a laboratory, as I have explained in several articles in the Townsend Letter.
In the beginning, when I started to use this molecular blood testing, I was obliged to spend considerable time studying and understanding the function of each gene. Of course, you have to know how to select natural agents that can reverse, activate, and inhibit various genes. I initially worked by experimentation and intuition. But it makes an overwhelming difference if you have a cancer patient with a mutated p53 gene or high levels of mutated p53 proteins, where the treatment has to be tailored according to the result. But this serves as only one example.
The other direction is the immune system which I have studied for decades but more seriously since I started to use RBAC [rice bran arabinoxylan compound]. Today we hear a different story, and nobody is currently just looking for the magic bullet to cure cancer. A few years ago, I began to develop more interest in the immune system fighting against cancer. Subsequently what surprised me, after oncologists denied and even criticized the power of immune cells to fight cancer, was a recent Sloan Kettering large public announcement that everyone is born with a defense system against cancer, meaning YOU! We already knew about this for a long time. The advertising said: Now oncology has introduced the latest breakthrough in cancer therapy. Can you believe this?! In any event, I have concentrated my research on the NK cell activity related to cancer and how to activate apoptosis using RBAC, but we never stop learning and reading updated documents.
When I started writing this book I was obliged if I may add, to engage in even more study about NK cells and update results about RBAC. Now RBAC is perhaps the most documented compound functioning as a biological response modifier that according to me should be included in all cancer protocols. In Japan, RBAC is considered a functional food and even used in more than 100 hospitals conjointly with chemotherapy and recommended by over 5000 doctors around the world.
So by both studying and working with my patients, this has shown me how RBAC contributes to reduce tumor size, decrease tumor markers, how it works in synergy with various anticancer agents and natural compounds like curcumin, for instance, to prevent or eliminate metastasis. RBAC contributes to increased lifespan with quality of life, but even better you can read about it in my book and see some examples with clinical cases illustrated with scans before and after the treatment. I can say that writing this book was beneficial for me since I was motivated to have done more studies.
One instance was more study about the anticancer properties of curcumin and a new excellent study on the synergistic apoptotic effects of both RBAC and curcumin in human MM cell lines in vitro. I wanted to see this for myself and made several experiments with metastatic breast cancer and a huge stomach tumor using only RBAC and liposomal curcumin. If together you target angiogenesis, for instance, using the C-statin compound from bindweed herb, with strong angiogenic properties you can expect some good results; but as I said, individual experience is the key to success since at the same time you are facing the patient and the success depends on how you handle it, as well as its attributes.
JT – Why were you inspired to write a new book focusing on immuno-oncology using rice bran arabinoxylan?
SJ – OK, first let me tell you that boosting the immune system with a cancer patient is not new to me for over 40 years. In 1986 I published in France, a book on cancer where I mentioned that the channel of immunotherapy may be the only way to treat cancer. It took an additional 35 years before oncology came to this conclusion. Immunotherapy has now become the fourth pillar of oncology, but again using toxic agents—not to mention the cost is very expensive and once again it turned into a big business.
For me the story of the RBAC began in 1992 when I was visited by one of my Japanese contacts who told me about a new compound developed in Japan, a rice bran arabinoxylan called Biobran, being very powerful to stimulate the immune system, especially the NK cells. I then began to experiment with my patients culminating in the excellent results we have today. In June 2017, I was participating in the 5th International Biobran (RBAC) workshop in Krakow, Poland, with the participation of various oncologists that themselves used RBAC. You can see my report in the Townsend Letter of October 2017.
Back then, for the first time, I met the general manager of Daiwa Lab (Japan), Mr. Nori Shirai, who after seeing my one-hour presentation, including several clinical cases with the protocol, came to me looking real enthusiastic, saying I should write a book including many clinical cases such as the ones that I had presented. I know what it means to write a book when after you start, during the next two or three years, you’ll be busy writing, searching, changing and not even have time for your own life. So, I asked for time to consider and see how I would develop the contents of the book.
While it was a challenge for me to write this book, I wanted to offer a new orientation to treat cancer, through activation of the immune cells, especially NK cells by using RBAC, which has shown efficacy over the past years. Not only is RBAC a strong immuno-modulator, but it has anti-inflammatory properties, decreases free radical activity, and is important for me that it modulates the Bcl2/Bax ratio, meaning an increase in apoptosis, but this has only been shown recently in a new study. During the past three years, I saw so many published articles speaking of a revolution in oncology by stimulating the immune system, I realized I had been given a reason to write this book.
I showed my own clinical experience in other approaches and diet and included a selection of 25 well-documented clinical cases. Daiwa’s president was pleased with the project, where Daiwa was in charge to publish the book. Having it distributed in over 50 countries, including the US, offered more reason for me to write the book. However, I didn’t expect so much time and energy would be spent to get the book finished in perfect US language. I devoted three years to this book, but in the end, I was rewarded.
JT– In your new book, you explain the role of p53 gene expression as the guardian of our immunity. This p53 gene is better known as the tumor suppressor gene. Can you tell us more?
SJ – Yes, most of us are acquainted with the p53 tumor suppressor gene as the guardian of our genome, being implicated in about half of all cancers. We know even less about some other important functions of the p53 gene, for instance, being the guardian of our immune integrity, which is one of the last discoveries of science concerning the p53 gene. Of course, this is all new and may be difficult to understand, but we just realized that the p53 gene is the maestro in a complex network of genes implicated in the case of cancer with immunosuppression, angiogenesis, inflammation, tumor invasion, and survival. If functioning normally, p53 gene can activate several immune mechanisms.
Another example, p53 is a transcription factor that can modulate checkpoints PD-1 and PD-L1 expression that blocks the immune system, specifically T-cells, and become a target in immunotherapy using the checkpoint drugs, Keytruda and Optivo. However, so far the results were still low, about 35%, along with side effects. There are at least two other mechanisms by which the p53 gene can activate immune cells to destroy cancer cells, such as by activation of an anti-tumor response via direct transcriptional regulation of the NK cell. The p53 gene can also modulate the tumor microenvironment that cancer cells use to grow and expand. Today the microenvironment is considered just as important as the tumor itself and needs a specific approach as well. This p53 gene can alter the host immune response, which is an additional way to increase the immune function to fight cancer.
But one other practically unknown function of p53 is the relation between the vitamin D receptor (VDR) gene that mediates the effects of vitamin D. We know that vitamin D modulates the activity of numerous immune cells. The expression of the VDR gene and then absorption of the vitamin D is induced by the normal p53 function but not by mutant p53.
Now we can understand why the p53 gene is so important when treating cancer and activating the immune system. The idea is to reactivate normal p53 function, using several selected natural compounds used to reverse immunosuppression and enhance anti-tumor activity. Of course, this is only a brief explanation, but you find all the details in my book.
This is why as I explained in the beginning, I wanted to devote a special chapter in my book about the p53 gene and its various functions, especially those linked with the immune system. Now we may better understand my response to attacking cancer cells both from direct activation of the immune cells and NK cells, while at the same time activating or reactivating p53 normal function, which contributes to an overall increased immune response. Why not call this a breakthrough in cancer treatment?
JT – Why do you believe oncologists do not focus more attention on the p53 gene in clinical practice?
SJ – We could also ask why they pay no attention to using other alternative methods when they face treatment failure? Today you find over 70,000 scientific publications about the p53 tumor suppressor gene, p53, and cancer. Every year there are conferences and a world congress organized on mutant p53, where reactivating mutant p53 is considered as an anticancer therapy, so what is the problem with oncologists? More recently researchers in Ireland have found a promising treatment for patients with TNBC, the most aggressive known breast cancer. They published the result of their study in the International Journal of Cancer under, “Mutant p53 a Novel target for the treatment of a patient with TNBC,”describing how a drug that targets the mutated p53 protein can largely inhibit the TNC cell proliferation and migration. So now we can say that the p53 gene may be one of the main keys in the treatment of cancer! According to my clinical experience, I can say yes.
Unfortunately, cancer theory is based on a deep-rooted dogma, and for far too long chemotherapy and radiation have remained the routine cornerstone of research by a laboratory in search of new miraculous drugs. I believe that today oncologists just work like robotic computers following what they all learned, conforming to what they are being told to do in the hospital. They are not yet ready to change their protocol, even if p53 mutation is an obstacle to chemotherapy.
Considering p53 mutation in clinical practice would support a new treatment paradigm with the use of natural compounds besides chemotherapy for which I believe oncologists are not yet prepared. Also, consider many alternative-medicine cancer doctors still do not understand the importance of the p53 tumor suppressor gene concerning cancer. I could give a further example when on one occasion where after sending my abstract to speak at an International Congress of Alternative Breast Cancer in the US, I received a negative reply: Not sufficient interest in a topic for this Congress! I could not believe such an attitude from alternative doctors knowing that p53 gene expression is one of the main keys when treating cancer, especially breast cancer. But on both sides require an open mind.
Let me quote you from Professor Ben Peiffer, oncologist at the Aesculap Clinic in Switzerland who also works with RBAC in his cancer protocol who has often stated, “You need to have an open mind.” He was a professor of oncology in New York, but one day his sister was diagnosed with cancer and came to New York for treatment by her brother, but unfortunately she died. That woke him up but as he said, it is very difficult to get out of the system that you have been taught. He decided to return to Switzerland and opened a clinic where he could treat cancer patients differently. His cancer protocol included stimulation of the immune system using RBAC and activation of apoptosis.
Unfortunately, in the Western world, most oncologists are still closed to any new paradigm, even those with scientific support such as the p53 tumor suppressor gene that responds to the use of natural compounds, simply because they are not independent and must be under the umbrella of Big Pharma or chemotherapy/radiation, so this may answer your question.
JT – What lifestyle and dietary rules and habits do you follow personally?
SJ – This is an interesting question because I have many colleagues that just live without dietary rules since they just do a job like any other and over the years most have passed on from heart disease or cancer. First, you have to be convinced that you need certain rules regarding food and a balanced lifestyle or way of living. Don’t forget that naturopathy is also a philosophy of life.
Now let me tell you upon meeting Dr. Bernard Jensen back in 1962, he enthusiastically invited me to his Hidden Valley Health Ranch. I saw for myself the importance of nutrition and a balanced food diet not only as a recovery therapy but as a way to keep our body and mind healthy. So at that time, it changed my own life and my food style because for me it was a way to show more respect for my body and just stay on natural organic food and not junk food. All my life and also for my wife, we adhere to some important dietary rules, the first with food quality. We buy only organic vegetables and fruits, but we also have our own small organic garden. We only use natural organic non-industrial food, whole food, fresh fish caught during the night in the market the following morning. We also prepare every day our fresh organic vegetable juice that always include red beets, which to me is one of the most healthy of the main anticancer foods.
In my book, Health and Disease Begin in the Colon, I have included 10 recipes for healthy soups, for a different purpose than we usually eat at home. We do follow mini-fasting in our diet with 16-18 hours between dinner and breakfast the next day, when we have only a cocktail of vegetable juice or some fruit with kefir or a salad in the afternoon. This is important, because at our age it keeps us healthier, you can be sure of this. We offer ourselves as an example of being healthy.
During the past 50 years, we always take several daily supplements but always include coenzyme Q10, vitamin C, magnesium, selenium, NADH, enzyme yeast cell preparation, CGF, chlorella tablets, and RBAC, to offer a few examples. Concerning my lifestyle, it is more difficult when you have been busy as I have been for several decades, traveling as I did; but I always set aside time for some sports, a lot of swimming, running, and participated in several triathlon competitions. But now I just build my lifestyle according to my age and keep swimming in my pool or spend summers at the beach and take a daily walk in the forest where I live. To tell you the truth at the moment we have to worry more about our health and immune system facing not only the risk of cancer but this pandemic; and good nutrition, dietary styles are our best weapon to keep away from infection and cancer.
JT – Can you please summarize the latest cancer treatment breakthroughs?
SJ – For over 20 years we have been used to reading about cancer in magazines like the New York Times, that this is the breakthrough we’ve been waiting for. Now, this is new ammunition in the war against cancer. Not a joke, but in 2007 the director of the National Cancer Institute announced the year 2015 as a deadline for the elimination of suffering and death caused by cancer. Of course, this false declaration was reported with pleasure by the media, yet where are we today with cancer and suffering patients? Where are we today with all the promised breakthroughs? We are still far from realizing this declaration since cancer is still dangerously on the increase. Finally, we all agree that classical treatment is not giving the desired results.
Mechanisms that are now considered as treatment using the body’s [ability to] attack are the reason for the title of my book called, Cancer Treatment Breakthrough, but I should better say breakthroughs since I am explaining other advances in cancer. If the fight is within, then besides the immune system, we have to recognize that apoptosis through the function of the p53 gene expression is also as much or even more important; and when it will be recognized, then we can speak of another breakthrough. I have read somewhere in an article calling to boost tumor death, that cancer treatment needed two important approaches. Optimize both p53 and immune support, but this is what I have already been doing for so many years.
Now you have to understand that with either classical oncology or alternative medicine there is no one miraculous remedy that can cure cancer. We need to set up multiple approaches, which today are recognized by many oncologists. Now please remember that each patient is an individual from a genetic standpoint. We have many types of cancers since it is not just one disease; we also have different stages of cancer. We have cancer cells with resistance, tumors without metastasis, or cancers that have spread in various organs; so you can better understand the complexity of treating cancer because each patient has his/her unique cancer.
President Obama proclaimed the only theoretical advancement of medicine is to present what they call a personalized and precision medicine, but by doing what? Cancers look similar, but there are differences in the way they grow and spread. This is what we accomplish with our molecular markers testing since no two patients with similar cancer show the same molecular markers testing results; both are different.
I have researched and read a paper online called, “Advances and Breakthroughs in Cancer Treatment”’; but it only discusses the classical approach of surgery, chemo/radiation, monoclonal antibodies, cart-t-cell therapy, immunotherapy, mutations in the cancer cells, but there is nothing different. What about apoptosis and if the p53 tumor suppressor gene is mutated, which occurs in about 50% of all cancers? What is oncology doing about testing patients?
Oncology is missing something important, but we know that science and medicine never get along since today medicine is too industrialized to move in other directions. The real breakthrough in cancer must include a combination of therapies that attack cancer in as many directions as possible using non-toxic agents. I have presented this approach in my book. I have included a chapter on the p53 gene since, as I have already explained, it is also known as the guardian of our immunity, inhibits glucose transporters, and modulates telomerase activity. When recognized, it will be another breakthrough.
Of course, restoring the activity of NK cells is important, since they are really special immune cells that can kill cancer cells directly. We know that in cancer NK cells are functioning only from 20-50% of their activity, they are not always ready to fight; and it seems that NK cells are more important than any other immune cells but lately seem to attract more attention in cancer treatment.
In Cancers (Volume 11, Issue 1, January 2019) the main article title on the cover is named, “NK cell-based immunotherapy in cancer metastasis,” and is presented as a new way to treat cancer. You’ll see in my book, case study examples on metastasis elimination. Do we now have a new breakthrough?!
Now another advance I would like to mention which I am working on for a couple of years is associated with the telomerase/p53 ratio, which I discussed in my last article in the Townsend Letter (August/Sept 2020). I believe we have here a new advance in diagnostic and treatment since we know that telomerase activity is expressed in 85% of cancer but modulated by normal active p53 gene while telomerase is activated when p53 gene is mutated. With highly activated telomerase, cancer cells increase survival and even become immortal.
This is a new way to diagnose cancer by measuring the ratio telomerase/p53 gene, but this has never been done before; but I believe it may be one of the most important breakthroughs. We can reverse the bad ratio by using several natural agents, for example, curcumin and genistein. I believe we have here a new way to diagnose cancer and make a prognostic, so here we have a personalized and precision medicine. Now by using a total immune approach—NK cells, p53 gene, the microbiome—we can call integrative immuno-oncology. I developed a poster, “Holistic Approach to Cancer Treatment,” with a figure that shows exactly how cancer must be approached that I use in my clinic with cancer patients. I will gladly send this poster to any doctor who asks.
JT – Why do people currently face such a high risk of contracting cancer and today the various SARS-Covid viruses?
SJ – Yes, we all are asking why so many people today are at high risk to develop cancer. Now in the year 1900, one person out of 100 was at risk of developing cancer but now we are at one out of three people, so the important question is why? I believe that the increased risk of cancer is associated with the development of our industrial society—the abuse of chemicals in the air, food, water, electromagnetic fields, but also, and we don’t mention, the excess of pharmaceutical drugs. Now, if we blame pollution to be the first factor that may lead to cancer, let me tell you that pharmaceutical drugs may also come in at first or second place. Pharmaceutical drugs en masse appeared over 50 years ago.
When I first arrived in Portugal, cancer was a rare disease, where today you have two or three family members with cancer. For example, between 2005 and 2015, cancer diagnoses increased by 33% worldwide with prostate and breast cancers. Both cancers are hormone-disrupting diseases. Thanks to the entry of Portugal in the ECC, this opened the door to the importation of industrial food and other modern food along with establishing industrial agriculture and pharmaceutical companies. As a result, medicine became an industry. Today junk food, McDonald’s, is the favorite food of juveniles and even whole families. Over the past decade, humans have abused pharmaceutical drugs in such a way that it has deteriorated our bodies. Today, as a result, people are without any defense against the current pandemic.
Did you know that many drugs, including antibiotics, are damaging to mitochondria function, and we know now that mitochondria are directly associated with cancer? Over the generations, the body has lost much of the capacity of its defense mechanism; and it is true for the immune defense, one important line of protection against cancer.
I have read the interesting article by Ross Pelton, PhD, “The Microbiome-COVID-19 Connection,” in the Townsend Letter (May 2021) where he proposed that mankind has experienced a gradual decline in immune function and disruption of the gut microbiome. I totally agree with him. Today many people have a serious deficiency in detoxification enzymes; and, if living or working in a polluted environment, they have a high risk of cancer. Pollution may also affect NK cells and cause mutation of the p53 gene—insecticide, for example—so here again we have the risk of cancer.
Another wrong theory is that cancer is a disease of age, but not anymore. It’s found more and more in those middle-aged and younger. Just let me give one example among many others: A 26-year-old woman ballet dancer was diagnosed with lung cancer and metastasis already spread to the bone and the liver. She came with her family to my clinic. Of course, she got worse from chemotherapy with metastasis having spread to the brain. She started smoking only three years before being diagnosed, so probably her cancer started long before smoking but this is only one example of what has gone wrong in our society.
Over the years we have in a way, created a condition where our body is no longer in a position to defend itself against disease. This gives you the answer for people with the risk of SARS and COVID-19 viruses. Lately, it has been shown that people infected with the SARS virus have a serious deficiency in vitamins C, D, zinc, and selenium. In both cases with cancer and COVID-19, the natural killer cells are implicated. Now during a pandemic, you see who is healthy or not. Without changing our lifestyle, food styles need to be more independent from toxic pharmaceutical drugs and vaccination. I am afraid that we will have to face increased cancer risk and more pandemics in the near future if we do not improve our health condition.
JT – Where have you taught and lectured?
SJ – Well, I’ll just answer briefly. I have traveled and lectured in about 36 countries on three continents. During 1970-1980 when I started to travel, I gave my first lecture in September 1972 in New York City at the International Congress of Cancer Victims and Friends and again at the same congress in 1974 in Los Angeles. At that time, we didn’t have Google, and we could learn only by meeting other colleagues at conferences, going to some clinics to learn, read books, etc. I came back several times to the US and participated in several seminars on integrative medicine and worked to develop the oxidative dried blood test with my late friend, Robert Bradford, PhD, who organized several seminars in San Diego, but also in different cities in Europe annually.
I also had a very good experience after being invited in 1985 to Sri Lanka to speak at a large world congress of alternative medicine. At that time, I met the health minister and the minister of traditional medicine. Immediately the health minister invited me to stay in Colombo for some time to learn how I treat cancer patients in the Hospital of Colombo, which I did. One other nice experience was to be invited by the University of Vilnius, Faculty of Medicine, Lithuania to give a seminar on the topic, “A Complementary and Alternative Lecture on New Avenues for Treatment in Oncology,” where I presented, in a combination therapy, the activation of the immune system using RBAC followed by clinical cases. Can you believe such a thing happening in other European countries?
I also lectured in Korea, invited by the President of the Korean Society of Traditional Medicine. More recently I was surprised but honored to be invited to the BIT’s 4th Annual Congress and exposition of molecular diagnosis in Beijing, China, to present my work on the p53 tumor suppressor gene and therapy. Travel became for me a reason not only to offer lectures but, especially, to learn from the other lecturers. Learning more is part of my life, and still today I spend considerable time studying and learning.
This article was originally published in Townsend Letter, August/September 2021.
About the Authors
Serge Jurasunas is an internationally well-known practitioner and researcher in complementary oncology and molecular medicine, a pioneer in naturopathic medicine and live blood analysis, with 55 years of experience in a private clinic. He is a professor of naturopathic oncology and has delivered lectures all over the world. He has been a frequent contributor to the Townsend Letter for 22 years. He is the author of two books in English, including Cancer Treatment Breakthrough – Immuno-Oncology using Rice Bran Arabinoxylan Compound, and Health and Disease Begin in the Colon Featuring Prof. Serge Jurasunas’ Natural Medicine.
Email: sergejurasunas@gmail.com;
Blog: https/naturopathiconcology.blogspot.com;
Skype: serge jurasunas
Dr. Jamie Turndorf is known to millions as Dr. Love through her website: Ask DrLove.com. She is the host of the “Love Never Dies” radio show, syndicated in 136 countries. Dr. Turndorf talks about love on Binge Network TV. She is the author of many international bestsellers, including her latest book, If You Think You Don’t Have PTSD – Think Again.